HIGHLIGHTS
- who: The RPL and collaborators from the Department, Xinjiang Bazhou People`s Hospital, Xinjiang, China, Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China have published the paper: The RPL4P4 Pseudogene Is a Prognostic Biomarker and Is Associated with Immune Infiltration in Glioma, in the Journal: Oxidative Medicine and Cellular Longevity of 23/06/2022
- what: To further understand the potential role of RPL4P4 in glioma, this study investigated the diagnostic and prognostic significance of RPL4P4 in glioma by data mining datasets from TCGA, GTEx, and CGGA. Interestingly, the analysis showed that RPL4P4 expression was . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.